Showing 1 - 4 results of 4 for search 'Simona Di Giambenedetto', query time: 0.02s Refine Results
  1. 1
    Investigating seroprevalence of IgG antibodies against Monkeypox Virus (MPXV) in a cohort of people living with HIV (PLWH) in Rome, during the 2022 outbreak: Moving beyond traditional at-risk populations

    Investigating seroprevalence of IgG antibodies against Monkeypox Virus (MPXV) in a cohort of people living with HIV (PLWH) in Rome, during the 2022 outbreak: Moving beyond traditio... by Pierluigi Francesco Salvo, Alessia Sanfilippo, Gianmaria Baldin, Valentina Iannone, Arturo Ciccullo, Damiano Farinacci, Domenico Benvenuto, Alberto Borghetti, Simona Di Giambenedetto, Francesca Lombardi

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Sleep Disorders Are Associated with Mental Health, Quality of Life and Stigma in an Italian Cohort of People Living with HIV

    Sleep Disorders Are Associated with Mental Health, Quality of Life and Stigma in an Italian Cohort of People Living with HIV by Valentina Massaroni, Valentina Delle Donne, Francesca Lombardi, Arturo Ciccullo, Valentina Iannone, Pierluigi Francesco Salvo, Daniela Pia Rosaria Chieffo, Valentina Arcangeli, Nicoletta Ciccarelli, Simona Di Giambenedetto

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Estimating risk of acquiring SARS-COV2 infection in treatment-experienced PLWH: A case-control study

    Estimating risk of acquiring SARS-COV2 infection in treatment-experienced PLWH: A case-control study by Pierluigi Francesco Salvo, Valentina Iannone, Francesca Lombardi, Arturo Ciccullo, Francesco Lamanna, Rosa Anna Passerotto, Gianmaria Baldin, Rebecca Jo Steiner, Andrea Carbone, Valentina Massaroni, Simona Di Giambenedetto, Alberto Borghetti

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Unconventional use of injectable long-acting cabotegravir and rilpivirine against HIV-1 in PWH in clinical need: 52 weeks real-world data

    Unconventional use of injectable long-acting cabotegravir and rilpivirine against HIV-1 in PWH in clinical need: 52 weeks real-world data by Valentina Iannone, Roberto Rossotti, Nicholas Brian Bana, Gabriele Cavazza, Federico D’Amico, Francesca Lombardi, Pierluigi Francesco Salvo, Gianmaria Baldin, Simona Di Giambenedetto, Dario Bernacchia, Gabriele Pagani, Alberto Borghetti, Stefano Rusconi

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: